← Back to Search

Other

Silver Diamine Fluoride for Molar Hypomineralization

N/A
Recruiting
Led By James Boynton, DDS
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at least two weeks following application of sdf or placebo on the enrolled tooth

Summary

This trial is testing if applying a special liquid called silver diamine fluoride (SDF) before dental procedures can help numb teeth better and reduce pain for patients with sensitive teeth due to a condition called molar-incisor hypomineralization (MIH). MIH makes teeth more sensitive and harder to treat with regular anesthesia. SDF works by blocking tiny holes in the teeth and making them stronger, which could help make dental treatments less painful. SDF has been used for many years to control early childhood cavities, stop root cavities, prevent various types of cavities, reduce tooth sensitivity, strengthen weak teeth, prevent dental erosion, detect decayed tissue during treatment, and manage infected root canals.

Who is the study for?
This trial is for children with a condition called molar-incisor hypomineralization who need dental work done on their molars. They should be generally healthy or have mild systemic disease, able to understand English, and manageable with basic non-drug guidance or laughing gas during dental procedures.
What is being tested?
The study tests if applying a solution called Silver Diamine Fluoride (SDF) before giving local anesthesia helps reduce pain better than a placebo when treating sensitive molars. It's randomized, meaning patients are put into the SDF or placebo group by chance.
What are the potential side effects?
Possible side effects of SDF include temporary staining of the skin and mucous membranes near application site, metallic taste in mouth, and very rarely an allergic reaction if there's sensitivity to silver.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at least two weeks following application of sdf or placebo on the enrolled tooth
This trial's timeline: 3 weeks for screening, Varies for treatment, and at least two weeks following application of sdf or placebo on the enrolled tooth for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Sixou and Barbosa-Rogier scale for local anesthesia efficacy
Secondary study objectives
Schiff Cold Air Sensitivity Scale
Other study objectives
Face, Legs, Activity, Cry, Consolability (FLACC) Scale

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: SDFExperimental Treatment1 Intervention
38% SDF applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.
Group II: PlaceboPlacebo Group1 Intervention
Inert liquid (colored water) applied to hypomineralized permanent molar two weeks prior to restorative care of the tooth.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SDF
2018
Completed Phase 3
~1570

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Local anesthesia works by blocking nerve conduction, specifically by inhibiting sodium channels on the nerve cell membrane, which prevents the initiation and transmission of nerve impulses. This results in a temporary loss of sensation in the targeted area. Treatments like lidocaine and bupivacaine are commonly used local anesthetics. The application of 38% Silver Diamine Fluoride (SDF) has been studied for its potential to enhance the efficacy of local anesthesia and reduce procedural pain, particularly in hypomineralized molars. This is significant for patients as it can lead to more effective pain management and a more comfortable experience during dental procedures.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,857 Previous Clinical Trials
6,437,166 Total Patients Enrolled
James Boynton, DDSPrincipal InvestigatorUniversity of Michigan

Media Library

Placebo (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05964387 — N/A
Local Anesthesia Research Study Groups: SDF, Placebo
Local Anesthesia Clinical Trial 2023: Placebo Highlights & Side Effects. Trial Name: NCT05964387 — N/A
Placebo (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05964387 — N/A
~20 spots leftby Dec 2025